Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study.
Hata T, Yasui M, Murata K, Okuyama M, Ohue M, Ikeda M, Ueshima S, Kitani K, Hasegawa J, Tamagawa H, Fujii M, Ohkawa A, Kato T, Morita S, Fukuzaki T, Mizushima T, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-Center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO). Hata T, et al. Surg Today. 2014 Nov;44(11):2116-23. doi: 10.1007/s00595-014-0911-7. Epub 2014 May 20. Surg Today. 2014. PMID: 24840400 Free PMC article.
Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer.
Mizushima T, Tamagawa H, Matsuda C, Murata K, Fukunaga M, Ota H, Hasegawa J, Tsujie M, Fukuzaki T, Hata T, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Mizushima T, et al. Among authors: matsuda c. Oncology. 2015;89(3):152-8. doi: 10.1159/000381718. Epub 2015 May 8. Oncology. 2015. PMID: 25967649 Clinical Trial.
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer.
Matsuda C, Uemura M, Nakata K, Shingai T, Nishimura J, Hata T, Ikenaga M, Takemasa I, Mizushima T, Kato T, Ikeda M, Ohue M, Murata K, Hasegawa J, Satoh T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Matsuda C, et al. BMC Cancer. 2015 Jun 3;15:452. doi: 10.1186/s12885-015-1476-6. BMC Cancer. 2015. PMID: 26036466 Free PMC article. Clinical Trial.
Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.
Nishizawa Y, Nishida N, Konno M, Kawamoto K, Asai A, Koseki J, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Mizushima T, Satoh T, Doki Y, Mori M, Ishii H. Nishizawa Y, et al. Among authors: matsuda c. Ann Surg Oncol. 2017 Mar;24(3):841-849. doi: 10.1245/s10434-016-5395-9. Epub 2016 Jul 29. Ann Surg Oncol. 2017. PMID: 27473587
Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K, Uemura M, Munakata K, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Ikenaga M, Murata K, Mizushima T, Yamamoto H, Doki Y, Mori M. Kawai K, et al. Among authors: matsuda c. Int J Oncol. 2017 Feb;50(2):525-534. doi: 10.3892/ijo.2016.3814. Epub 2016 Dec 20. Int J Oncol. 2017. PMID: 28000858
[Recurrence of Jejunal Carcinoma in the Ileum and Ovary - A Case Report].
Ohara N, Haraguchi N, Kudo T, Takahashi H, Nishimura J, Hata T, Matsuda C, Satoh T, Mizushima T, Yamamoto H, Doki Y, Mori M. Ohara N, et al. Among authors: matsuda c. Gan To Kagaku Ryoho. 2016 Nov;43(12):1803-1805. Gan To Kagaku Ryoho. 2016. PMID: 28133137 Japanese.
287 results